PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Divisão de Urologia, A.C. Camargo Cancer Center, Fundação A. Prudente, São Paulo, Brasil.\', \'Instituto Nacional de Ciência e Tecnologia em Oncogenômica e Inovação Terapêutica - INCIT - INOTE, A. C. Camargo Cancer Center, Fundação A. Prudente, São Paulo, Brasil.\', \'Latin American Renal Cancer Group - LARCG, São Paulo, SP, Brasil.\', \'Department of Urology, Pasteur Hospital, Montevideo, Uruguay.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1590/S1677-5538.IBJU.2020.S108
?:doi
?:hasPublicationType
?:journal
  • International braz j urol : official journal of the Brazilian Society of Urology
is ?:pmid of
?:pmid
?:pmid
  • 32549075
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all